Ribavirin and interferon∝-2b combination therapy for 48 weeks in patients with chronic hepatitis C who either failed (non-responder) or relapsed (relapsers) from previous interferon monotherapy.

被引：0
|
作者：
Tsai, NC
Coste, A
Shimoda, N
Yee, H
Jao, R
Wong, L
Buto, S
Shimoda, S
机构：
[1] Univ Hawaii, Honolulu, HI 96822 USA
[2] St Francis Med Ctr, Honolulu, HI USA
[3] Univ Hawaii, Honolulu, HI 96822 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
429
引用
收藏
页码：268A / 268A
页数：1
相关论文
共 50 条
  • [21] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers.
    Jacobson, I
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Rovner, D
    Brass, C
    HEPATOLOGY, 2002, 36 (04) : 358A - 358A
  • [22] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers.
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Pizov, O
    Brass, C
    HEPATOLOGY, 2001, 34 (04) : 338A - 338A
  • [23] Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone
    Milella, M
    Santantonio, T
    Pietromatera, G
    Maselli, R
    Casalino, C
    Mariano, N
    Genchi, C
    Pastore, G
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (03): : 211 - 215
  • [24] Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed interferon therapy.
    Birdi, PK
    Wustrack, S
    Rostetter, E
    King, JW
    Balart, LA
    GASTROENTEROLOGY, 2000, 118 (04) : A1426 - A1426
  • [25] Ribavirin/interferon α-2b (IFN) therapy is very effective in the treatment of chronic hepatitis C genotype 2&3 patients who have failed to respond virologically to IFN monotherapy.
    Pimstone, NR
    Canio, JB
    Chiang, MH
    Kokosinski, J
    Powell, JS
    Saicheur, T
    Sheykhzadeh, PI
    Yu, AS
    GASTROENTEROLOGY, 2001, 120 (05) : A382 - A382
  • [26] Interferon α2b and ribavirin vs interferon α2b and amantadine for chronic hepatitis C (non-responder):: A multi-center, randomized, double-blind trial
    Younossi, ZM
    Mullen, KD
    Zakko, W
    Brandt, E
    Hodnick, S
    Easley, K
    Barnes, D
    Carey, WD
    McCullough, AJ
    HEPATOLOGY, 1998, 28 (04) : 284A - 284A
  • [27] Efficacy of interferon-alpha 2b in combination with ribavirin in the treatment of non-responder patients with chronic hepatitis C: A randomised-controlled trial.
    Tassopoulos, NC
    Tsantoulas, D
    Raptopoulou, M
    Paraskevas, E
    Avgerinos, A
    Kanatakis, S
    Vaffiadis, I
    Delladetsima, J
    Demonakou, M
    Sypsa, V
    Hatzakis, A
    HEPATOLOGY, 1999, 30 (04) : 632A - 632A
  • [28] Double-dose peginterferon-α2b induction plus ribavirin in chronic hepatitis C patients with previous nonresponse to interferon monotherapy or combination therapy with ribavirin
    Bergmann, J. F.
    Vrolijk, J. M.
    van der Schaar, P.
    van Erpecum, K. J.
    van Hoek, B.
    Veer, A. van der Sluys
    deVries, R.
    Hansen, B. E.
    Janssen, H. L. A.
    Schalm, S. W.
    de Knegt, R. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (10) : A71 - A71
  • [29] Combination therapy with interferon and ribavirin for treatment of patients with chronic Hepatitis C who have failed therapy with interferon alone.
    Lynch, PJ
    Jacobsmeyer, S
    Quigley, M
    Peters, MG
    HEPATOLOGY, 1998, 28 (04) : 576A - 576A
  • [30] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers: Final results
    Jacobson, IM
    Ahmed, F
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Brau, N
    Tobias, H
    Klion, F
    Bini, E
    Brodsky, N
    Rovner, D
    Brass, C
    GASTROENTEROLOGY, 2003, 124 (04) : A714 - A714
12345